GL1X · GenesisL1 explorer

Research workbench

Ternary complex of an orally active thrombin inhibitor with human thrombin and a C-terminal hirudin derived exo-sit inhibitor

Analyse Ternary complex of an orally active thrombin inhibitor with human thrombin and… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ANM
Type
protein
Length
284 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thrombin
EC
3.4.21.5
UniProt
P00734
Ligands
CDO
Pockets
3 · best druggability 0.55

Structure

x-ray diffraction · 2 distinct chains · 15% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HThrombin (EC 3.4.21.5)protein25014% helix, 35% strandP00734
LThrombin (EC 3.4.21.5)protein3424% helix, 0% strandP00734

Ligands and binding sites

  • CDO · 2-((R)-1-((S)-2-(N-(6-carbamimidoylpyridin-3-yl)methylcarbamoyl)-2H-pyrrol-1(5H)-yl)-3-cyclohexyl-1-oxopropan-2-ylamino)acetic acid · ligand · chains H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12540.550.7736CDO
2580.370.7914empty
3650.360.7721empty

Interfaces

1 interface between chains.

  • H–L · 1379 Ų buried · 31 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 2ANM · Ternary complex of an orally active thrombin inhibitor with human thrombin and a… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.